SCIACOVELLI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 7.604
AS - Asia 3.269
EU - Europa 2.663
AF - Africa 653
SA - Sud America 640
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 61
Totale 14.981
Nazione #
US - Stati Uniti d'America 7.209
IT - Italia 1.285
SG - Singapore 1.068
CN - Cina 584
BR - Brasile 402
VN - Vietnam 349
HK - Hong Kong 288
PL - Polonia 174
FR - Francia 143
BD - Bangladesh 135
DE - Germania 105
FI - Finlandia 104
IN - India 100
SE - Svezia 100
RU - Federazione Russa 88
GB - Regno Unito 86
NL - Olanda 86
CA - Canada 79
JP - Giappone 60
AR - Argentina 55
ID - Indonesia 53
IQ - Iraq 48
UA - Ucraina 41
TR - Turchia 40
MX - Messico 38
PH - Filippine 38
EC - Ecuador 36
ES - Italia 36
ZA - Sudafrica 36
SA - Arabia Saudita 31
TN - Tunisia 31
EG - Egitto 29
PK - Pakistan 29
MU - Mauritius 28
MA - Marocco 26
UZ - Uzbekistan 26
VE - Venezuela 25
ET - Etiopia 24
NI - Nicaragua 24
PT - Portogallo 24
CO - Colombia 23
PS - Palestinian Territory 23
RO - Romania 23
AZ - Azerbaigian 22
CI - Costa d'Avorio 22
GR - Grecia 22
PE - Perù 22
AE - Emirati Arabi Uniti 21
AT - Austria 21
MY - Malesia 21
AO - Angola 20
GT - Guatemala 20
KR - Corea 20
LC - Santa Lucia 20
NP - Nepal 20
TH - Thailandia 20
BA - Bosnia-Erzegovina 19
CG - Congo 19
CL - Cile 19
HU - Ungheria 19
IE - Irlanda 19
KE - Kenya 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
BF - Burkina Faso 18
CR - Costa Rica 18
CU - Cuba 18
DZ - Algeria 18
LB - Libano 18
NO - Norvegia 18
PY - Paraguay 18
UG - Uganda 18
YE - Yemen 18
CH - Svizzera 17
DO - Repubblica Dominicana 17
EE - Estonia 17
GN - Guinea 17
KG - Kirghizistan 17
KZ - Kazakistan 17
MG - Madagascar 17
PA - Panama 17
TJ - Tagikistan 17
TZ - Tanzania 17
ZW - Zimbabwe 17
AL - Albania 16
GE - Georgia 16
HN - Honduras 16
JM - Giamaica 16
LU - Lussemburgo 16
LY - Libia 16
ME - Montenegro 16
RW - Ruanda 16
UY - Uruguay 16
BJ - Benin 15
BS - Bahamas 15
BZ - Belize 15
IS - Islanda 15
KH - Cambogia 15
NC - Nuova Caledonia 15
SK - Slovacchia (Repubblica Slovacca) 15
Totale 14.253
Città #
Fairfield 796
Ashburn 781
San Jose 715
Singapore 669
Woodbridge 484
Houston 351
Ann Arbor 292
Cambridge 291
Chandler 271
Seattle 271
Hong Kong 260
Wilmington 248
Council Bluffs 148
Bytom 141
Milan 118
Santa Clara 117
Ho Chi Minh City 112
Beijing 109
Boardman 97
Princeton 92
Hanoi 89
Los Angeles 89
San Diego 82
Rome 71
Lauterbourg 65
Medford 65
Helsinki 58
New York 48
Padova 45
Jacksonville 43
Nanjing 43
Des Moines 42
Dallas 41
Roxbury 41
Florence 37
São Paulo 35
Atlanta 34
Trento 34
Chicago 32
Tokyo 32
Bologna 28
Tashkent 24
Managua 23
Naples 23
Baku 22
Buffalo 21
London 21
Abidjan 20
Castries 20
Frankfurt am Main 20
Jinan 20
Genoa 19
Haiphong 18
Montreal 18
Munich 18
San Francisco 18
Vientiane 18
Brasília 17
Conakry 17
Hebei 17
Kampala 17
Nairobi 17
Antananarivo 16
Guangzhou 16
Harare 16
Havana 16
Kigali 16
Montevideo 16
Panama City 16
Shenyang 16
Ulan Bator 16
Baghdad 15
Da Nang 15
Dar es Salaam 15
Dublin 15
Johannesburg 15
Nanchang 15
Noumea 15
Orem 15
San José 15
Dong Ket 14
Luanda 14
Lusaka 14
Nassau 14
Ouagadougou 14
Warsaw 14
Amman 13
Bishkek 13
Cotonou 13
Dakar 13
Dushanbe 13
Guatemala City 13
Luxembourg 13
Phnom Penh 13
Rio de Janeiro 13
Shanghai 13
Trieste 13
Addis Ababa 12
Kingstown 12
Niamey 12
Totale 8.367
Nome #
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 698
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 652
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 516
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 402
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 330
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 284
What information on measurement uncertainty should be communicated to clinicians, and how? 264
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 247
Quality indicators to detect pre-analytical errors in laboratory testing 245
Harmonization of pre-analytical quality indicators. 244
Performance criteria and quality indicators for the pre-analytical phase. 235
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 229
Extra-analytical sources of uncertainty: which ones really matter? 223
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 221
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 219
Decision Support and Patient Safety 218
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 214
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 213
An integrated system for monitoring the quality of sample transportation. 210
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 210
Assessment of package inserts for diagnostic kits. 209
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 208
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 205
An Italian External Quality Assessment (EQA) program on urinary sediment. 203
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 202
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 202
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 201
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 198
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 190
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 190
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 190
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 187
External quality assessment programs in the context of ISO 15189 accreditation 183
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 182
Performance specifications of critical results management 180
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 180
Reference intervals: Are interlaboratory differences appropriate? 179
Once upon a time: A tale of ISO 15189 accreditation 177
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 174
Effects of sample transportation on commonly requested laboratory tests. 170
External Quality Assessment Schemes: need for recognised requirements 169
Preanalytical challenges - time for solutions 169
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 169
Measurement uncertainty: Light in the shadows 169
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 168
Quality indicators for laboratory diagnostics: consensus is needed. 168
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 168
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 168
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 166
Risk management in laboratory medicine: quality assurance programs and professional competence. 164
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 161
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 160
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 158
Quality specifications in EQA schemes: from theory to practice 157
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 157
The silk road to total quality in Laboratory Medicine 157
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 157
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 157
Importance of control materials in quality assessment of cyclosporine determination. 156
Extra-analytical quality indicators and laboratory performances 156
Extra-analytical quality indicators - Where to now? 153
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 150
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 147
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 147
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 145
Post-standardization of routine creatinine assays: are they suitable for clinical applications 141
Critical laboratory results: communication is just one of the problems. 141
Quality Indicators for the Total Testing Process 138
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 125
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 116
IFCC project “Model of quality indicators”: a method for results evaluation 114
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 113
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 107
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 106
Totale 14.981
Categoria #
all - tutte 41.790
article - articoli 37.545
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022751 0 0 0 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20266.355 227 564 938 1.123 569 229 631 574 619 417 254 210
2026/20271.597 323 792 272 210 0 0 0 0 0 0 0 0
Totale 14.981